Megan M. Weivoda, Ph.D.

Contact Us for the Latest Status

• Development Of A Normal Hematologic Resource For The Evaluation Of Aging Mechanisms In Myeloma, Amyloid, And Dysproteinemia Diseases Rochester, Minn.

  The incidence of monoclonal gammopathies and progression to multiple myeloma increases with aging. In order to separate the characteristics of pre-malignant/malignant plasma cells and their microenvironment from normal aging, patient samples and functional assessments need to be evaluated in comparison to healthy, aged participants. With this study, we will recruit healthy, aged partipcants to create a normal hematologic aging resource.